Trial on safety and immunogenicity of Ebola vaccines yields promising results

Close up of chemical microscope and medical research equipment in scientific laboratory. Liquid examination tool with glass lens and blood samples in vacutainers on professional desk

Ebola epidemics occur periodically in various sub-Saharan African countries. While vaccines exist and have already received WHO Prequalification against the Zaire ebolavirus species, it is essential to pursue and intensify efforts to supplement the available data to develop a safe and effective Ebola vaccine strategies in adults and children alike.

Researchers find new, safer treatment for serious side effect of bone marrow transplant

Previous article

Researchers investigate the multi-omic landscape of steatosis-to-NASH progression in mice

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations